Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
ASX:BXN
Total Valuation
Bioxyne Limited has a market cap or net worth of AU$56.29M. The enterprise value is AU$23.60M.
Market CapAU$56.29M
Enterprise ValueAU$23.60M
Share Statistics
Bioxyne Limited has 2,164,828,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,164,828,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioxyne Limited’s return on equity (ROE) is -3.70 and return on invested capital (ROIC) is -40.77%.
Return on Equity (ROE)-3.70
Return on Assets (ROA)-1.99
Return on Invested Capital (ROIC)-40.77%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee582.81K
Profits Per Employee-799.94K
Employee Count16
Asset Turnover1.39
Inventory Turnover3.56
Valuation Ratios
The current PE Ratio of Bioxyne Limited is -0.72. Bioxyne Limited’s PEG ratio is -0.14.
PE Ratio-0.72
PS Ratio0.00
PB Ratio1.78
Price to Fair Value2.68
Price to FCF-29.94
Price to Operating Cash Flow-31.95
PEG Ratio-0.14
Income Statement
In the last 12 months, Bioxyne Limited had revenue of 9.33M and earned -13.33M in profits. Earnings per share was -0.01.
Revenue9.33M
Gross Profit1.71M
Operating Income-1.66M
Pretax Income-13.29M
Net Income-13.33M
EBITDA-1.08M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 1.57M and capital expenditures -1.47M, giving a free cash flow of 108.08K billion.
Operating Cash Flow1.57M
Free Cash Flow108.08K
Free Cash Flow per Share<0.01
Dividends & Yields
Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change200.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)60.38
Average Volume (3m)2.19M
Important Dates
Bioxyne Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Bioxyne Limited as a current ratio of 1.92, with Debt / Equity ratio of 3.69%
Current Ratio1.92
Quick Ratio1.18
Debt to Market Cap0.00
Net Debt to EBITDA0.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bioxyne Limited has paid -310.64K in taxes.
Income Tax-310.64K
Effective Tax Rate0.02
Enterprise Valuation
Bioxyne Limited EV to EBITDA ratio is -8.59, with an EV/FCF ratio of -2.29.
EV to Sales1.00
EV to EBITDA-8.59
EV to Free Cash Flow-2.29
EV to Operating Cash Flow-2.61
Balance Sheet
Bioxyne Limited has AU$2.68M in cash and marketable securities with AU$1.73M in debt, giving a net cash position of -AU$945.45K billion.
Cash & Marketable SecuritiesAU$2.68M
Total DebtAU$1.73M
Net Cash-AU$945.45K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 6.65%, with operating margin of -17.79%, and net profit margin of -142.90%.
Gross Margin6.65%
Operating Margin-17.79%
Pretax Margin-142.47%
Net Profit Margin-142.90%
EBITDA Margin-11.61%
EBIT Margin-17.79%
Analyst Forecast
The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast98.57%
EPS Growth Forecast―